Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine
Daniel B Zandman, Mark A PeppercornHarvard Medical School, Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Mesalamine and its derivatives are effective and well-tolerated therapies for ulcerative colitis. However, patient adherence...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-03-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/patient-considerations-in-the-management-of-ulcerative-colitis-role-of-a2998 |